- Home
- NVO vs AMZN Comparison
NVO vs AMZN Comparison
Compare NVO & AMZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | AMZN |
|---|---|---|
| Founded | 1923 | 1994 |
| Country | Denmark | United States |
| Employees | 69500 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Catalog/Specialty Distribution |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.4B | 2.6T |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | NVO | AMZN |
|---|---|---|
| Price | $47.26 | $235.43 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 42 |
| Target Price | $51.00 | ★ $285.88 |
| AVG Volume (30 Days) | 12.0M | ★ 40.4M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 3.19% | N/A |
| EPS Growth | N/A | ★ 29.66 |
| EPS | N/A | ★ 2.78 |
| Revenue | N/A | ★ $716,924,000,000.00 |
| Revenue This Year | N/A | $14.63 |
| Revenue Next Year | $3.70 | $11.81 |
| P/E Ratio | ★ $13.60 | $84.28 |
| Revenue Growth | N/A | ★ 12.38 |
| 52 Week Low | $35.12 | $196.00 |
| 52 Week High | $71.80 | $278.56 |
Technical Indicators
Market Signals| Indicator | NVO | AMZN |
|---|---|---|
| Relative Strength Index (RSI) | 64.55 | 39.34 |
| Support Level | $45.62 | $215.97 |
| Resistance Level | $47.79 | $238.97 |
| Average True Range (ATR) | 1.39 | 7.68 |
| MACD | 0.40 | -1.42 |
| Stochastic Oscillator | 95.31 | 14.66 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About AMZN Amazon.com Inc.
Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 74% of total, followed by Amazon Web Services (17%), and advertising services (9%). International segments constitute 22% of Amazon's total revenue, led by Germany, the United Kingdom, and Japan.